Trial designThe diabetic postoperative mortality and morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery
Section snippets
Trial design
The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial is a randomized, double-blind, placebo-controlled, multicenter trial, launched on July 1, 2000. Randomization was completed on June 30, 2002 with 921 patients included. The primary aim of the trial was to assess the long-term effect of 7-day perioperative β-blockade on perioperative and postoperative mortality and cardiac morbidity in patients with diabetes mellitus who were undergoing major noncardiac surgery.
Current status of the trial
From July 2000 to January 2002 (the scheduled period of recruitment), 725 patients were enrolled. The average monthly recruitment for the entire study was 43 patients/month. The DIPOM Steering Committee decided to extend the period of recruitment by 6 months. The last patient was randomized on July 1, 2002. A total of 2066 candidate patients were identified in the 13 centers (Figure 1), and, of these, 921 patients (45%) were randomized (Table III). Baseline characteristics of the randomized
Design features
The design of the DIPOM trial differs from that of previous perioperative β-blocker trials. First, it is a large multicenter trial with increased power to measure outcomes after a minimum of 6 months (median, 18 months) of follow-up. In-hospital outcomes and outcomes at 30 days will also be reported. Second, only patients who were β-blocker naive were included, because β-blocker withdrawal may increase the risk of postoperative cardiovascular morbidity and mortality.34 Third, patients with
Conclusion
DIPOM is, according to our knowledge, the first trial examining the effects of perioperative β-blocker administration on outcomes, including mortality and cardiac morbidity, in patients with diabetes mellitus. The results of the study may have implications for therapeutic measures in a growing and threatened patient population. If the trial shows that perioperative β-blockade reduces postoperative mortality and morbidity rates in patients with diabetes mellitus, this will be an important
Acknowledgements
We thank the patients who participated in the DIPOM trial, the surgeons at the surgical departments for their excellent collaboration, AstraZeneca for helpful discussions and excellent collaboration during the design and inclusion phase of the DIPOM trial and for free supply of the study drug, and AstraZeneca, the Danish Heart Foundation, the Danish Diabetes Foundation, the Copenhagen Hospital Corporation's Research Council, and the Danish Medical Research Council's “Program for Strengthening
References (42)
- et al.
Perioperative myocardial ischemia in patients undergoing noncardiac surgery—IIIncidence and severity during the 1st week after surgery. The Study of Perioperative Ischemia (SPI) Research Group
J Am Coll Cardiol
(1991) - et al.
Acute myocardial infarction in the diabetic patientPathophysiology, clinical course and prognosis
J Am Coll Cardiol
(1992) - et al.
Perioperative beta-blocker withdrawal and mortality in vascular surgical patients
Am Heart J
(2001) Perioperative cardiac morbidity
Anesthesiology
(1990)- et al.
Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group
N Engl J Med
(1990) - et al.
In-hospital and long-term mortality in male veterans following noncardiac surgery. The Study of Perioperative Ischemia Research Group
JAMA
(1992) - et al.
Long-term cardiac prognosis following noncardiac surgery. The Study of Perioperative Ischemia Research Group
JAMA
(1992) - et al.
Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group
Anesthesiology
(1998) - et al.
Silent myocardial ischemia monitoring predicts late as well as perioperative cardiac events in patients undergoing vascular surgery
J Vasc Surg
(1992) - et al.
Detection and significance of intraoperative and postoperative myocardial ischemia in peripheral vascular surgery
JAMA
(1992)